Quest Diagnostics

DGX · NYSE · USD

$233.33Change from previous close: +0.97%Absolute change: +$2.24

Close · October 2, 2026

At a glance

Revenue growth
+11.78%
2025 vs 2024
Net income growth
+13.89%
2025 vs 2024
Net margin
9.0%
2024: 8.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets16,93916,67316,22516,19715,969—
Current assets2,8442,5662,3782,4072,198—
Cash and equivalents626393420432319—
Receivables1,6661,5871,4081,4561,419—
Inventory233225189186187—
Net property, plant and equipment2,8972,8802,8602,7942,775—
Goodwill9,1129,1208,9458,9018,883—
Other intangible assets1,6721,7171,6361,6621,706—
Long-term investments137134136137136—
Current liabilities1,7882,1772,2782,1342,024—
Accounts payable——307———
Long-term debt5,6325,1555,1675,1715,169—
Total debt6,3836,4066,5856,3826,384—
Total liabilities9,0408,9288,9398,8218,623—
Total equity (incl. minority)7,8997,7457,2867,3767,346—
Retained earnings10,37410,1519,9949,8379,682—
Minority interest383379116118118—